Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Return on Capital Employed (2016 - 2025)

Traws Pharma (TRAW) has disclosed Return on Capital Employed for 13 consecutive years, with 22.98% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed rose 293.0% to 22.98% in Q3 2025 year-over-year; TTM through Sep 2025 was 22.98%, a 293.0% increase, with the full-year FY2024 number at 11.59%, down 1065.0% from a year prior.
  • Return on Capital Employed was 22.98% for Q3 2025 at Traws Pharma, up from 26.29% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.32% in Q4 2021 to a low of 26.29% in Q4 2024.
  • A 5-year average of 5.95% and a median of 0.88% in 2021 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: tumbled -2499bps in 2024, then surged 293bps in 2025.
  • Traws Pharma's Return on Capital Employed stood at 0.32% in 2021, then tumbled by -83bps to 0.59% in 2022, then tumbled by -122bps to 1.3% in 2023, then plummeted by -1926bps to 26.29% in 2024, then rose by 13bps to 22.98% in 2025.
  • Per Business Quant, the three most recent readings for TRAW's Return on Capital Employed are 22.98% (Q3 2025), 26.29% (Q4 2024), and 25.91% (Q3 2024).